New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Authors
Keywords
Paclitaxel, Docetaxel, Epithelial-to-mesenchymal transition (EMT), Drug resistance, Chemoresistance, Metastasis
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 141, Issue -, Pages 111824
Publisher
Elsevier BV
Online
2021-06-25
DOI
10.1016/j.biopha.2021.111824
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer
- (2021) Fariba Pishbin et al. Personalized Medicine
- Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines
- (2021) Hiroki Hosoi et al. GENE
- The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer
- (2021) Rahul Sreekumar et al. Molecular Oncology
- YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
- (2020) Barry J. Thompson BIOESSAYS
- p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer
- (2020) Martina Gruber et al. ENDOCRINE-RELATED CANCER
- Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance
- (2020) Lokesh Kaushik et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- miR-124 and miR-203 synergistically inactivate EMT pathway via coregulation of ZEB2 in clear cell renal cell carcinoma (ccRCC)
- (2020) Jiajia Chen et al. Journal of Translational Medicine
- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial
- (2020) John A Bridgewater et al. LANCET ONCOLOGY
- Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1
- (2020) Xiaohong Hong et al. Molecular Cancer
- MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer
- (2020) Xin Tong et al. ONCOGENE
- TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression
- (2020) Shangfeng Sun et al. PROTOPLASMA
- Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production
- (2020) Xiangyu Zhang et al. OncoTargets and Therapy
- Knockdown of FOXO6 Inhibits Glycolysis and Reduces Cell Resistance to Paclitaxel in HCC Cells via PI3K/Akt Signaling Pathway
- (2020) Xixiang Yu et al. OncoTargets and Therapy
- KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells
- (2020) Junyi Pu et al. Artificial Cells Nanomedicine and Biotechnology
- DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
- (2020) Eva Galle et al. Clinical Epigenetics
- Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B
- (2020) Jun Cui et al. Aging-US
- Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition
- (2020) Lingyu Kong et al. Aging-US
- Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells
- (2020) Zhi-jie Liu et al. ANTI-CANCER DRUGS
- RNA m 6 A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy
- (2020) Ziyou Lin et al. EMBO JOURNAL
- Long noncoding RNA H19 acts as a miR ‐340‐3p sponge to promote epithelial‐mesenchymal transition by regulating YWHAZ expression in paclitaxel‐resistant breast cancer cells
- (2020) Lei Yan et al. ENVIRONMENTAL TOXICOLOGY
- ROS and oncogenesis with special reference to EMT and stemness
- (2020) Ritam Chatterjee et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
- (2020) Choudhary Harsha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
- (2020) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
- (2020) Ajaz A. Bhat et al. Molecular Cancer
- Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance
- (2020) Ping Zhong et al. MOLECULAR PHARMACEUTICS
- LINC01272 Promotes Migration and Invasion of Gastric Cancer Cells via EMT
- (2020) Xue Leng et al. OncoTargets and Therapy
- lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
- (2020) Ran Wang et al. OncoTargets and Therapy
- MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
- (2020) Honglei Wu et al. Cell Death & Disease
- Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer
- (2020) Zhiyu Wang et al. Drug Design Development and Therapy
- Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes
- (2020) Thomas M. Pausch et al. Scientific Reports
- c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors
- (2020) Antonia Strippoli et al. Cancers
- Unresolved Complexity in the Gene Regulatory Network Underlying EMT
- (2020) Deborah P. Lavin et al. Frontiers in Oncology
- HOTAIR expands the population of prostatic cancer stem-like cells and causes Docetaxel resistance via activating STAT3 signaling
- (2020) Ning Wang et al. Aging-US
- Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells
- (2020) Liyun Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Hypoxia –inhibited miR‐338‐3p suppresses breast cancer progression by directly targeting ZEB2
- (2020) Juanjuan He et al. CANCER SCIENCE
- Effects of propofol on the development of cancer in humans
- (2020) Yichi Xu et al. CELL PROLIFERATION
- MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma
- (2020) Chengyi Jiang et al. Genes & Genomics
- EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration
- (2020) Daisy Y. Shu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
- (2020) Milad Ashrafizadeh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel
- (2020) Karan Modi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LINC00160 mediated paclitaxel‐And doxorubicin‐resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ
- (2020) Huaiguo Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
- (2020) Cefan Zhou et al. Molecular Cancer
- Nanoparticle-based co-delivery of siRNA and paclitaxel for dual-targeting of glioblastoma
- (2020) Jun Yang et al. Nanomedicine
- RUNX1 regulates TGF-β induced migration and EMT in colorectal cancer
- (2020) Chenghao Lu et al. PATHOLOGY RESEARCH AND PRACTICE
- Sphk1 participates in malignant progression of breast cancer by regulating epithelial-mesenchymal transition and stem cell characteristics
- (2020) Zhijie Chen et al. TISSUE & CELL
- Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer
- (2020) Ji Ma et al. Cell Death & Disease
- EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
- (2020) Anthony Genna et al. Cancers
- EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment
- (2020) Yaqi Tang et al. Cancers
- Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer
- (2020) Milad Ashrafizadeh et al. Biomolecules
- MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy
- (2020) Milad Ashrafizadeh et al. Biomolecules
- Luteolin enhances TRAIL sensitivity in non-small cell lung cancer cells through increasing DR5 expression and Drp1-mediated mitochondrial fission
- (2020) Bin Wu et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Esomeprazole overcomes paclitaxel‐resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells
- (2020) Zhaoshi Bai et al. CELL BIOLOGY INTERNATIONAL
- Wilms’ tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling
- (2020) Yun Han et al. CELL CYCLE
- MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
- (2020) Milad Ashrafizadeh et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer
- (2020) Lian Deng et al. International Journal of Nanomedicine
- A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
- (2020) Monique B. Nilsson et al. Science Translational Medicine
- Multi‐Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor
- (2020) Reza Taheri‐Ledari et al. Small
- Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer
- (2020) Haoran Feng et al. Cell Death & Disease
- Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
- (2020) Mayuko Miyamoto et al. Scientific Reports
- Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer
- (2020) Houbao Huang et al. Frontiers in Oncology
- Corilagin Represses Epithelial to Mesenchymal Transition Process Through Modulating Wnt/β-Catenin Signaling Cascade
- (2020) Sun Tae Hwang et al. Biomolecules
- EDIL3 promotes epithelial–mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells
- (2020) J. Gasca et al. Cell Death Discovery
- The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer
- (2020) Teng Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- c‐Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
- (2020) Tsung‐Ming Chang et al. CANCER SCIENCE
- Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
- (2020) Ievgenia Pastushenko et al. NATURE
- A variant of H19 transcript regulates EMT and oral cancer progression
- (2020) Wu Zhou et al. ORAL DISEASES
- The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer
- (2020) Mark Bates et al. PLoS One
- TRPS1 and YAP1 Regulate Cell Proliferation and Drug Resistance of Osteosarcoma via Competitively Binding to the Target of circTADA2A – miR-129-5p
- (2020) Jinyu Zhang et al. OncoTargets and Therapy
- SLC12A8 plays a key role in bladder cancer progression and EMT
- (2020) Shun-Lai Li et al. Open Medicine
- FBXW7 in Cancer: What Has Been Unraveled Thus Far?
- (2019) Bethsebie Lalduhsaki Sailo et al. Cancers
- KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells
- (2019) Jinyuan Li et al. LIFE SCIENCES
- SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel
- (2019) Yangyang Shi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The expanding roles of long non-coding RNAs in the regulation of cancer stem cells
- (2019) Zhaowu Ma et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The role of heterogeneous environment and docetaxel gradient in the emergence of polyploid, mesenchymal and resistant prostate cancer cells
- (2019) Ke-Chih Lin et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
- (2019) Jilai Tian et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulation of Epithelial Mesenchymal Transition under Compliant Polydimethylsiloxane Substrate
- (2019) Mousumi Mandal et al. BIOPHYSICAL JOURNAL
- Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
- (2019) Satish Patel et al. BIOMEDICINE & PHARMACOTHERAPY
- Combination of Human Umbilical Vein Endothelial Cell Vaccine and Docetaxel Generates Synergistic Anti-Breast Cancer Effects
- (2019) Meiyu Lu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer
- (2019) Shengling Fu et al. CANCER LETTERS
- Therapeutic efficacy of anti‐MMP9 antibody in combination with nab‐paclitaxel‐based chemotherapy in pre‐clinical models of pancreatic cancer
- (2019) Niranjan Awasthi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Brassinin Represses Invasive Potential of Lung Carcinoma Cells through Deactivation of PI3K/Akt/mTOR Signaling Cascade
- (2019) Min Hee Yang et al. MOLECULES
- Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer
- (2019) Xiangyu Zhang et al. Drug Design Development and Therapy
- The MAP3K13-TRIM25-FBXW7α axis affects c-Myc protein stability and tumor development
- (2019) Qiang Zhang et al. CELL DEATH AND DIFFERENTIATION
- Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells
- (2019) Yue-Yue Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells
- (2019) Sun Tae Hwang et al. PHYTOMEDICINE
- LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer
- (2019) Huan Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models
- (2019) Clarissa Esmeralda Halim et al. PHARMACOLOGICAL RESEARCH
- Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling
- (2019) Dattatrya Shetti et al. Cells
- The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
- (2019) Loh et al. Cells
- Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition
- (2019) Jun-Ting Cheng et al. Cells
- YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling
- (2019) Grace E. Coggins et al. CANCER RESEARCH
- EZH2 loss drives resistance to carboplatin and paclitaxel in serous ovarian cancers expressing ATM
- (2019) Johanna Naskou et al. MOLECULAR CANCER RESEARCH
- c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression
- (2019) Wen Jing Sim et al. Nature Communications
- Overexpressed long non-coding RNA GATA6-AS1 inhibits lymph node metastasis and epithelial mesenchymal transition via FZD4 through the Wnt/β-catenin signaling pathway in gastric cancer
- (2019) Zheng-Tian Li et al. Molecular Therapy-Nucleic Acids
- The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
- (2019) Fan Liang et al. Oncogenesis
- Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib
- (2019) Chengzhong Lin et al. CANCER LETTERS
- FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy
- (2019) Jian-zhong Lin et al. CANCER LETTERS
- FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
- (2019) Chao Liu et al. CANCER LETTERS
- Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel
- (2019) Zhiyuan Shen et al. CANCER LETTERS
- Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer
- (2019) Aya Naiki-Ito et al. CARCINOGENESIS
- Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer
- (2019) Fei Guo et al. CELL DEATH AND DIFFERENTIATION
- LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p
- (2019) Xingkang Jiang et al. CELLULAR SIGNALLING
- MiR‐129‐5p promotes docetaxel resistance in prostate cancer by down‐regulating CAMK2N1 expression
- (2019) Cheng Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma
- (2019) Xiaoqiang Si et al. MOLECULAR CARCINOGENESIS
- Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway
- (2019) Jong Hyun Lee et al. PHARMACOLOGICAL RESEARCH
- The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells
- (2019) Martina Gruber et al. PROSTATE
- circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252
- (2019) Shu Zhang et al. Molecular Therapy-Nucleic Acids
- mi R -27b and mi R -34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1
- (2018) Guangwei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
- (2018) Lingzhi Wang et al. CANCER LETTERS
- Nab-paclitaxel interrupts cancer-stromal interaction through C-X-C motif chemokine 10-mediated interleukin-6 downregulation in vitro
- (2018) Rui Feng et al. CANCER SCIENCE
- Triple negative breast cancer in Asia: An insider’s view
- (2018) Chao Wang et al. CANCER TREATMENT REVIEWS
- Hyaluronic Acid-Methotrexate Conjugates Coated Magnetic Polydopamine Nanoparticles for Multimodal Imaging-Guided Multistage Targeted Chemo-Photothermal Therapy
- (2018) Qi Li et al. MOLECULAR PHARMACEUTICS
- Bergamottin Suppresses Metastasis of Lung Cancer Cells through Abrogation of Diverse Oncogenic Signaling Cascades and Epithelial-to-Mesenchymal Transition
- (2018) Jeong-Hyeon Ko et al. MOLECULES
- Potential role of genipin in cancer therapy
- (2018) Muthu K. Shanmugam et al. PHARMACOLOGICAL RESEARCH
- Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells
- (2018) Jong Hyun Lee et al. PHYTOMEDICINE
- Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review
- (2018) Gautam Sethi et al. Nutrients
- Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α
- (2018) Jiang Qian et al. Biomed Research International
- Role of tumor-derived exosomes in cancer metastasis
- (2018) Ian Wee et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- All-trans retinoic acid reverses epithelial-mesenchymal transition in paclitaxel-resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions
- (2018) Guiling Shi et al. CANCER SCIENCE
- Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer
- (2018) Xin Wu et al. Cell Death & Disease
- lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells
- (2018) Peide Huang et al. Scientific Reports
- Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis
- (2018) Muthu K. Shanmugam et al. Frontiers in Pharmacology
- Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
- (2018) Gurubharathi Bhuvanalakshmi et al. Cancers
- SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells
- (2017) Chun-Yan Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
- (2017) Wanpei Cai et al. JNCI-Journal of the National Cancer Institute
- PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers
- (2017) Luxi Chen et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer
- (2017) Marguerite L. Palisoul et al. MOLECULAR CANCER THERAPEUTICS
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis
- (2017) Daisy Y. Shu et al. PROGRESS IN RETINAL AND EYE RESEARCH
- The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- (2017) Youxiang Hou et al. Cell Death & Disease
- Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer
- (2017) C. Allison Stewart et al. Oncotarget
- Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer
- (2017) Jian-Zhong Lin et al. Oncotarget
- Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway
- (2017) Yan Pan et al. Oncotarget
- WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel
- (2017) Mara Artibani et al. Scientific Reports
- Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
- (2017) Wanpei Cai et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4
- (2017) G. Bhuvanalakshmi et al. Frontiers in Pharmacology
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma
- (2017) Ganlu Deng et al. Scientific Reports
- Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment
- (2017) Leonardo A. Moraes et al. Scientific Reports
- Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells
- (2016) Mei-ling Han et al. ACTA PHARMACOLOGICA SINICA
- Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma
- (2016) Ser Yue Loo et al. ANTIOXIDANTS & REDOX SIGNALING
- INPP4B reverses docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer
- (2016) Haiwen Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cardiac Fibrosis
- (2016) Joshua G. Travers et al. CIRCULATION RESEARCH
- Epithelial-to-Mesenchymal Transition in Paclitaxel-Resistant Ovarian Cancer Cells Is Downregulated by Luteolin
- (2016) Vermont P Dia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SH003 enhances paclitaxel chemosensitivity in MCF-7/PAX breast cancer cells through inhibition of MDR1 activity
- (2016) Hyeong Sim Choi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
- (2016) Xiaoyun Dai et al. MOLECULAR CANCER THERAPEUTICS
- Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
- (2016) Luigi Ippolito et al. Oncotarget
- ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation
- (2016) Yi Yuan et al. Oncotarget
- microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
- (2015) Jen N. Goh et al. BIOLOGICAL REVIEWS
- Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
- (2015) J A Galván et al. BRITISH JOURNAL OF CANCER
- AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis
- (2015) Yu Ren et al. CANCER LETTERS
- CD90+stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer
- (2015) Phuong T. Huynh et al. INTERNATIONAL JOURNAL OF CANCER
- Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression
- (2015) Martina Tholen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma
- (2015) Hongping Xia et al. JOURNAL OF HEPATOLOGY
- The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
- (2015) Anamaria Brozovic et al. Molecular Oncology
- Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor-β-mediated epithelial-mesenchymal transition
- (2015) QINGQING ZHANG et al. ONCOLOGY REPORTS
- SphK1 promotes tumor cell migration and invasion in colorectal cancer
- (2015) Jianting Long et al. TUMOR BIOLOGY
- Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells
- (2015) K. D. M. Nakamura et al. TUMOR BIOLOGY
- Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature
- (2015) Bao-An Chen et al. OncoTargets and Therapy
- Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel
- (2015) WENXING HE et al. Experimental and Therapeutic Medicine
- MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells
- (2015) Qingling Yang et al. Oncotarget
- Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
- (2015) So-Yeon Park et al. Oncotarget
- Natural Bioactives in Cancer Treatment and Prevention
- (2015) Yih-Shou Hsieh et al. Biomed Research International
- Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
- (2014) Q Yang et al. BRITISH JOURNAL OF CANCER
- KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
- (2014) Diane D. Shao et al. CELL
- MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc
- (2014) Dongqin Chen et al. EUROPEAN JOURNAL OF CANCER
- DEAD-box helicase DP103 defines metastatic potential of human breast cancers
- (2014) Eun Myoung Shin et al. JOURNAL OF CLINICAL INVESTIGATION
- Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
- (2014) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
- (2014) Francois Moisan et al. Molecular Oncology
- Epithelial-Mesenchymal Transition Contributes to Docetaxel Resistance in Human Non-Small Cell Lung Cancer
- (2014) Weiwei Shen et al. ONCOLOGY RESEARCH
- Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
- (2013) Neta Erez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanistic insights into mode of action of novel natural cathepsin L inhibitors
- (2013) Chetna Tyagi et al. BMC GENOMICS
- Mesenchymal to epithelial transition in sarcomas
- (2013) Jilong Yang et al. EUROPEAN JOURNAL OF CANCER
- Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis
- (2013) Raunak Kumar Das et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells
- (2013) Urszula M. Polanska et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Human Lung Epithelial Cells Progressed to Malignancy through Specific Oncogenic Manipulations
- (2013) Mitsuo Sato et al. MOLECULAR CANCER RESEARCH
- Acquisition of paclitaxel resistance via PI3K-dependent epithelial-mesenchymal transition in A2780 human ovarian cancer cells
- (2013) FANGFANG DU et al. ONCOLOGY REPORTS
- Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line
- (2013) ATSUSHI HIROSE et al. Oncology Letters
- Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models
- (2013) Cathy C. Zhang et al. Stem Cells Translational Medicine
- Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line
- (2012) Jin Ren et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern
- (2011) Özlem Darcansoy İşeri et al. MOLECULAR BIOLOGY REPORTS
- Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis
- (2011) Barry S. Komm et al. Therapeutic Advances in Musculoskeletal Disease
- Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo
- (2010) Peramaiyan Rajendran et al. CLINICAL CANCER RESEARCH
- Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression
- (2010) Antonio Garcia de Herreros et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
- (2010) A. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- Signaling Mechanism(S) of Reactive Oxygen Species in Epithelial-Mesenchymal Transition Reminiscent of Cancer Stem Cells in Tumor Progression
- (2010) Zhiwei Wang et al. Current Stem Cell Research & Therapy
- EMT, the cytoskeleton, and cancer cell invasion
- (2009) Mahmut Yilmaz et al. CANCER AND METASTASIS REVIEWS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Exosomes – vesicular carriers for intercellular communication
- (2009) Mikael Simons et al. CURRENT OPINION IN CELL BIOLOGY
- CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
- (2009) Jian Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells
- (2008) Francesco Fabbri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Del-1, an Endogenous Leukocyte-Endothelial Adhesion Inhibitor, Limits Inflammatory Cell Recruitment
- (2008) E. Y. Choi et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now